ADAM Inhibitors
| Cat. No. | Product Name / Activity |
|---|---|
| 8826 | BAY 9835 New |
| Potent ADAMTS7 and ADAMTS12 inhibitor | |
| 3995 | GI 254023X |
| Selective ADAM10 metalloprotease inhibitor | |
| 7030 | GW 280264X |
| Potent ADAM10 and ADAM17 inhibitor | |
| 5523 | TAPI 0 |
| ADAM-17 (TACE) and MMP inhibitor | |
| 6162 | TAPI 1 |
| ADAM-17 (TACE) and MMP inhibitor | |
| 6013 | TAPI 2 |
| ADAM-17 (TACE) and MMP inhibitor | |
| 5960 | TMI 1 |
| Adam 17 (TACE) and MMP inhibitor; orally bioavailable |
Alzheimer's Life Science Poster
Written by Dimitra Sokolova and Soyon Hong
Our Alzheimer's disease poster summarizes the genetic, molecular and cellular changes observed in the progression of this neurodegenerative disease.
Request copyDownload PDF